All Posts:hormone receptor positive breast cancer

• ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times

  The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.

  Category: Lombardi Stories Tags: breast cancer, breast cancer research, cancer, clinical trials, hormone receptor positive breast cancer, triple-negative breast cancer